The goals of the Johns Hopkins Oncology Center's participation in the programs of the Eastern Cooperative Oncology Group are as follows: 1. To participate in the scientific development and conduct of clinical research through: a. The development of protocols as study chairman b. Participation in disease-oriented and modality-oriented committees c. Entry of patients into ECOG group-wide protocols and pilot studies 2. To participate in the administrative activities of the ECOG through membership in its various committees 3. To increase participation of the Johns Hopkins affiliated community hospitals in ECOG activities 4. To utilize The Johns Hopkins Oncology Center's expertise in experimental therapeutics to develop new therapeutic strategies which could be incorporated in ECOG protocols. The primary methodology used to achieve our goals is through the Oncology Center's leadership role in ECOG activities, participation in controlled clinical trials utilizing multimodality treatment programs and by having a strong and active affiliated community hospitals program. Scientific leadership from Johns Hopkins in ECOG has been primarily in the areas of lung cancer, breast cancer. malignant lymphoma, multiple myeloma, bone marrow transplantation, studies of new chemotherapeutic agents and oncology nursing research. Besides these areas, it is anticipated that scientific leadership from Johns Hopkins in ECOG will occur in the use of biologic response modifiers. Johns Hopkins is committed through our ECOG participation to provide cancer treatment programs and disseminated cancer-related information in order to improve and standardize cancer care given to patients. The high quality of our data will be maintained through excellent data management and by continuing quality control audits of data both at Johns Hopkins and in the affiliated members carried out both by """"""""in-house"""""""" and independent audit teams.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
5U10CA016116-17
Application #
3556357
Study Section
Cancer Clinical Investigation Review Committee (CCI)
Project Start
1978-06-01
Project End
1994-04-30
Budget Start
1990-05-01
Budget End
1991-04-30
Support Year
17
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
Schools of Medicine
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Moots, Paul L; O'Neill, Anne; Londer, Harold et al. (2018) Preradiation Chemotherapy for Adult High-risk Medulloblastoma: A Trial of the ECOG-ACRIN Cancer Research Group (E4397). Am J Clin Oncol 41:588-594
Gravis, Gwenaelle; Boher, Jean-Marie; Chen, Yu-Hui et al. (2018) Burden of Metastatic Castrate Naive Prostate Cancer Patients, to Identify Men More Likely to Benefit from Early Docetaxel: Further Analyses of CHAARTED and GETUG-AFU15 Studies. Eur Urol 73:847-855
Francis, Prudence A; Pagani, Olivia; Fleming, Gini F et al. (2018) Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer. N Engl J Med 379:122-137
Lemieux, Julie; Brundage, Michael D; Parulekar, Wendy R et al. (2018) Quality of Life From Canadian Cancer Trials Group MA.17R: A Randomized Trial of Extending Adjuvant Letrozole to 10 Years. J Clin Oncol 36:563-571
Saha, Poornima; Regan, Meredith M; Pagani, Olivia et al. (2017) Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials. J Clin Oncol 35:3113-3122
Regan, M M; Walley, B A; Francis, P A et al. (2017) Concurrent and sequential initiation of ovarian function suppression with chemotherapy in premenopausal women with endocrine-responsive early breast cancer: an exploratory analysis of TEXT and SOFT. Ann Oncol 28:2225-2232
Bhatia, Aarti K; Lee, Ju-Whei; Pinto, Harlan A et al. (2017) Double-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: Long-term follow-up of a trial of the Eastern Cooperative Oncology Group-ACRIN Cancer Research Group (C0590). Cancer 123:4653-4662
Agarwala, Sanjiv S; Lee, Sandra J; Yip, Waiki et al. (2017) Phase III Randomized Study of 4 Weeks of High-Dose Interferon-?-2b in Stage T2bNO, T3a-bNO, T4a-bNO, and T1-4N1a-2a (microscopic) Melanoma: A Trial of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Gro J Clin Oncol 35:885-892
Pine, Alexander B; Lee, Eun-Ju; Sekeres, Mikkael et al. (2017) Wide variations in blood product transfusion practices among providers who care for patients with acute leukemia in the United States. Transfusion 57:289-295
Sonpavde, Guru; Pond, Gregory R; Plets, Melissa et al. (2017) Validation of the Association of RECIST Changes With Survival in Men With Metastatic Castration-Resistant Prostate Cancer Treated on SWOG Study S0421. Clin Genitourin Cancer 15:635-641

Showing the most recent 10 out of 137 publications